Institute of Rehabilitation Medicine, Medical Faculty, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Interdisciplinary Center for Health Sciences, Medical Faculty, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
J Ren Care. 2022 Sep;48(3):177-184. doi: 10.1111/jorc.12397. Epub 2021 Sep 5.
Interprofessional teams and peer support are being increasingly considered in informed shared decision-making. In Germany, there appear to be deficits in the implementation of informed shared decision-making in the choice of renal replacement therapy, such as the lack of collaboration in interprofessional teams and the absence of structured peer support programmes for patients with chronic kidney disease.
To explore nephrologists' and nurses' perspectives regarding their involvement in shared decision-making when choosing renal replacement therapy.
Guideline-based, problem-centred interviews were used.
A total of 20 nephrologists and 15 nurses were recruited from 21 dialysis units all over Germany.
Interviews were audio-recorded and transcribed. They were analysed thematically using structuring and summary content analysis, supported by the qualitative data analysis software MAXQDA 12.
The most important findings were the late or missing participation of nurses in the informed shared decision-making process and the unstructured peer support. Along with time and financial factors, these aspects were seen as barriers to shared decision-making with patients who are often overwhelmed by the diagnosis. Furthermore, informed shared decision-making has been insufficiently considered in professional education and training.
Shared decision-making in the choice of renal replacement therapy is particularly challenging due to the patients' high disease burden. The greater incorporation of informed shared decision-making in education and training as well as the consistent involvement of nursing staff and structured peer counselling already in the predialysis phase with adequate reimbursement can address the identified hurdles.
在知情共享决策中,越来越多的人开始考虑采用多专业团队和同伴支持的方式。在德国,在选择肾脏替代疗法的知情共享决策的实施方面似乎存在一些缺陷,例如多专业团队协作不足,以及缺乏针对慢性肾脏病患者的结构化同伴支持计划。
探讨肾科医生和护士在选择肾脏替代疗法时参与共享决策的看法。
基于指南、以问题为中心的访谈。
共招募了来自德国 21 个透析中心的 20 名肾科医生和 15 名护士。
对访谈进行录音并转录。使用 MAXQDA 12 定性数据分析软件进行主题分析,采用结构化和总结内容分析。
最重要的发现是护士在知情共享决策过程中的参与时间晚或缺失,以及同伴支持缺乏结构。除了时间和财务因素外,这些方面被认为是与患者进行共享决策的障碍,因为患者经常被诊断所压垮。此外,知情共享决策在专业教育和培训中考虑不足。
由于患者的疾病负担较重,肾脏替代疗法选择中的共享决策特别具有挑战性。在教育和培训中更充分地纳入知情共享决策,并在透析前阶段就充分补偿的情况下,让护理人员和结构化的同伴咨询始终参与进来,可以解决已确定的障碍。